EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence and medicine: Mounting risks amid the promise

Bryn Nelson, William Faquin

Cancer Cytopathology · 2023

DOI: 10.1002/cncy.22739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2023. Verfasst von Bryn Nelson und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Medicine, Biomedical Research. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This news section is written by a medical journalist and offers Cancer Cytopathology readers timely information on events, issues, and personalities of interest to the subspecialty. In this second of a two‐part series, developers have touted artificial intelligence as a boon for both medical research and clinical applications, but plenty of pitfalls are giving ethicists and other experts considerable pause in their use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicineBiomedical ResearchHumansArtificial IntelligenceEthicists

Zitieren

APA

Nelson, B., & Faquin, W. (2023). Artificial intelligence and medicine: Mounting risks amid the promise. Cancer Cytopathology. https://doi.org/10.1002/cncy.22739

Vancouver

Nelson B, Faquin W. Artificial intelligence and medicine: Mounting risks amid the promise. Cancer Cytopathology. 2023. doi:10.1002/cncy.22739

BibTeX
@article{Nelson2023,
  author = {Nelson, Bryn and Faquin, William},
  title = {Artificial intelligence and medicine: Mounting risks amid the promise},
  journal = {Cancer Cytopathology},
  year = {2023},
  doi = {10.1002/cncy.22739}
}
Kostenlos starten →